nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—HSP90AA1—breast cancer	0.456	0.93	CbGaD
Rifabutin—CYP3A4—breast cancer	0.0343	0.0699	CbGaD
Rifabutin—CYP1A2—Anastrozole—breast cancer	0.0319	0.13	CbGbCtD
Rifabutin—CYP1A2—Toremifene—breast cancer	0.0292	0.119	CbGbCtD
Rifabutin—CYP3A4—Exemestane—breast cancer	0.022	0.0898	CbGbCtD
Rifabutin—CYP3A4—Letrozole—breast cancer	0.0187	0.0763	CbGbCtD
Rifabutin—CYP3A4—Anastrozole—breast cancer	0.0167	0.0681	CbGbCtD
Rifabutin—CYP3A4—Toremifene—breast cancer	0.0153	0.0622	CbGbCtD
Rifabutin—CYP3A4—Fulvestrant—breast cancer	0.0142	0.0579	CbGbCtD
Rifabutin—CYP3A4—Thiotepa—breast cancer	0.0127	0.0516	CbGbCtD
Rifabutin—CYP3A4—Ixabepilone—breast cancer	0.0116	0.0472	CbGbCtD
Rifabutin—CYP3A4—Lapatinib—breast cancer	0.0111	0.0454	CbGbCtD
Rifabutin—CYP1A2—Tamoxifen—breast cancer	0.0106	0.0434	CbGbCtD
Rifabutin—CYP3A4—Raloxifene—breast cancer	0.00844	0.0344	CbGbCtD
Rifabutin—CYP1A2—Fluorouracil—breast cancer	0.00785	0.032	CbGbCtD
Rifabutin—CYP3A4—Vinorelbine—breast cancer	0.00618	0.0252	CbGbCtD
Rifabutin—CYP3A4—Tamoxifen—breast cancer	0.00558	0.0227	CbGbCtD
Rifabutin—CYP3A4—Mitoxantrone—breast cancer	0.00544	0.0222	CbGbCtD
Rifabutin—CYP3A4—Paclitaxel—breast cancer	0.00434	0.0177	CbGbCtD
Rifabutin—CYP3A4—Irinotecan—breast cancer	0.00428	0.0175	CbGbCtD
Rifabutin—CYP3A4—Vinblastine—breast cancer	0.00381	0.0155	CbGbCtD
Rifabutin—HSP90B1—mammary gland—breast cancer	0.00326	0.0734	CbGeAlD
Rifabutin—CYP3A4—Docetaxel—breast cancer	0.00314	0.0128	CbGbCtD
Rifabutin—HSP90B1—nipple—breast cancer	0.0027	0.0607	CbGeAlD
Rifabutin—HSP90AA1—mammary gland—breast cancer	0.00239	0.0537	CbGeAlD
Rifabutin—CYP3A4—Doxorubicin—breast cancer	0.00234	0.00954	CbGbCtD
Rifabutin—HSP90B1—embryo—breast cancer	0.00223	0.0501	CbGeAlD
Rifabutin—HSP90AA1—nipple—breast cancer	0.00197	0.0444	CbGeAlD
Rifabutin—HSP90B1—epithelium—breast cancer	0.00182	0.0409	CbGeAlD
Rifabutin—HSP90B1—skin of body—breast cancer	0.00173	0.0389	CbGeAlD
Rifabutin—HSP90B1—endometrium—breast cancer	0.00163	0.0366	CbGeAlD
Rifabutin—HSP90AA1—embryo—breast cancer	0.00163	0.0366	CbGeAlD
Rifabutin—HSP90B1—uterus—breast cancer	0.0015	0.0338	CbGeAlD
Rifabutin—HSP90B1—pituitary gland—breast cancer	0.00148	0.0332	CbGeAlD
Rifabutin—HSP90B1—adipose tissue—breast cancer	0.00147	0.033	CbGeAlD
Rifabutin—HSP90B1—female reproductive system—breast cancer	0.00135	0.0304	CbGeAlD
Rifabutin—HSP90AA1—epithelium—breast cancer	0.00133	0.0299	CbGeAlD
Rifabutin—HSP90B1—adrenal gland—breast cancer	0.00132	0.0296	CbGeAlD
Rifabutin—HSP90B1—bone marrow—breast cancer	0.00127	0.0287	CbGeAlD
Rifabutin—HSP90AA1—skin of body—breast cancer	0.00126	0.0284	CbGeAlD
Rifabutin—HSP90B1—female gonad—breast cancer	0.00123	0.0276	CbGeAlD
Rifabutin—HSP90AA1—endometrium—breast cancer	0.00119	0.0268	CbGeAlD
Rifabutin—HSP90B1—endocrine gland—breast cancer	0.00114	0.0257	CbGeAlD
Rifabutin—HSP90AA1—uterus—breast cancer	0.0011	0.0247	CbGeAlD
Rifabutin—HSP90AA1—pituitary gland—breast cancer	0.00108	0.0243	CbGeAlD
Rifabutin—HSP90AA1—adipose tissue—breast cancer	0.00107	0.0242	CbGeAlD
Rifabutin—HSP90AA1—female reproductive system—breast cancer	0.000988	0.0222	CbGeAlD
Rifabutin—HSP90AA1—adrenal gland—breast cancer	0.000964	0.0217	CbGeAlD
Rifabutin—HSP90AA1—bone marrow—breast cancer	0.000932	0.021	CbGeAlD
Rifabutin—HSP90AA1—female gonad—breast cancer	0.000899	0.0202	CbGeAlD
Rifabutin—HSP90AA1—endocrine gland—breast cancer	0.000836	0.0188	CbGeAlD
Rifabutin—HSP90B1—lymph node—breast cancer	0.00079	0.0178	CbGeAlD
Rifabutin—Rifampicin—SLCO1B1—breast cancer	0.000661	0.279	CrCbGaD
Rifabutin—CYP1A2—nipple—breast cancer	0.000638	0.0143	CbGeAlD
Rifabutin—HSP90AA1—lymph node—breast cancer	0.000578	0.013	CbGeAlD
Rifabutin—Rifampicin—ABCC1—breast cancer	0.000545	0.23	CrCbGaD
Rifabutin—Rifaximin—CYP3A4—breast cancer	0.000401	0.169	CrCbGaD
Rifabutin—CYP1A2—endocrine gland—breast cancer	0.00027	0.00607	CbGeAlD
Rifabutin—Rifapentine—CYP2D6—breast cancer	0.000269	0.113	CrCbGaD
Rifabutin—CYP3A4—female reproductive system—breast cancer	0.000231	0.00519	CbGeAlD
Rifabutin—Rifapentine—CYP3A4—breast cancer	0.00023	0.0972	CrCbGaD
Rifabutin—CYP3A4—endocrine gland—breast cancer	0.000196	0.0044	CbGeAlD
Rifabutin—Rifampicin—CYP3A4—breast cancer	0.000144	0.0607	CrCbGaD
Rifabutin—Rifampicin—ABCB1—breast cancer	0.00012	0.0505	CrCbGaD
Rifabutin—Headache—Vinorelbine—breast cancer	5.12e-05	0.000459	CcSEcCtD
Rifabutin—Leukopenia—Docetaxel—breast cancer	5.11e-05	0.000459	CcSEcCtD
Rifabutin—Anaemia—Capecitabine—breast cancer	5.11e-05	0.000458	CcSEcCtD
Rifabutin—Body temperature increased—Fluorouracil—breast cancer	5.1e-05	0.000458	CcSEcCtD
Rifabutin—Eosinophilia—Doxorubicin—breast cancer	5.06e-05	0.000454	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Paclitaxel—breast cancer	5.01e-05	0.000449	CcSEcCtD
Rifabutin—Hepatobiliary disease—Methotrexate—breast cancer	4.98e-05	0.000447	CcSEcCtD
Rifabutin—Insomnia—Paclitaxel—breast cancer	4.97e-05	0.000446	CcSEcCtD
Rifabutin—Hypersensitivity—Irinotecan—breast cancer	4.97e-05	0.000446	CcSEcCtD
Rifabutin—Hypersensitivity—Mitoxantrone—breast cancer	4.97e-05	0.000446	CcSEcCtD
Rifabutin—Vomiting—Thiotepa—breast cancer	4.96e-05	0.000445	CcSEcCtD
Rifabutin—Leukopenia—Capecitabine—breast cancer	4.95e-05	0.000444	CcSEcCtD
Rifabutin—Convulsion—Docetaxel—breast cancer	4.95e-05	0.000444	CcSEcCtD
Rifabutin—Paraesthesia—Paclitaxel—breast cancer	4.94e-05	0.000443	CcSEcCtD
Rifabutin—Rash—Thiotepa—breast cancer	4.92e-05	0.000442	CcSEcCtD
Rifabutin—Dermatitis—Thiotepa—breast cancer	4.92e-05	0.000441	CcSEcCtD
Rifabutin—Agranulocytosis—Methotrexate—breast cancer	4.91e-05	0.000441	CcSEcCtD
Rifabutin—Dyspnoea—Paclitaxel—breast cancer	4.9e-05	0.00044	CcSEcCtD
Rifabutin—Headache—Thiotepa—breast cancer	4.89e-05	0.000439	CcSEcCtD
Rifabutin—Myalgia—Docetaxel—breast cancer	4.86e-05	0.000436	CcSEcCtD
Rifabutin—Chest pain—Docetaxel—breast cancer	4.86e-05	0.000436	CcSEcCtD
Rifabutin—Arthralgia—Docetaxel—breast cancer	4.86e-05	0.000436	CcSEcCtD
Rifabutin—Pancytopenia—Doxorubicin—breast cancer	4.86e-05	0.000436	CcSEcCtD
Rifabutin—Nausea—Vinorelbine—breast cancer	4.85e-05	0.000436	CcSEcCtD
Rifabutin—Dyspepsia—Paclitaxel—breast cancer	4.84e-05	0.000434	CcSEcCtD
Rifabutin—Asthenia—Irinotecan—breast cancer	4.84e-05	0.000434	CcSEcCtD
Rifabutin—Asthenia—Mitoxantrone—breast cancer	4.84e-05	0.000434	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	4.83e-05	0.000433	CcSEcCtD
Rifabutin—Jaundice—Epirubicin—breast cancer	4.8e-05	0.000431	CcSEcCtD
Rifabutin—Neutropenia—Doxorubicin—breast cancer	4.78e-05	0.000429	CcSEcCtD
Rifabutin—Decreased appetite—Paclitaxel—breast cancer	4.78e-05	0.000429	CcSEcCtD
Rifabutin—Hypersensitivity—Fluorouracil—breast cancer	4.76e-05	0.000427	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Paclitaxel—breast cancer	4.75e-05	0.000426	CcSEcCtD
Rifabutin—Hepatitis—Methotrexate—breast cancer	4.73e-05	0.000424	CcSEcCtD
Rifabutin—Asthenia—Gemcitabine—breast cancer	4.71e-05	0.000423	CcSEcCtD
Rifabutin—Myalgia—Capecitabine—breast cancer	4.71e-05	0.000422	CcSEcCtD
Rifabutin—Chest pain—Capecitabine—breast cancer	4.71e-05	0.000422	CcSEcCtD
Rifabutin—Arthralgia—Capecitabine—breast cancer	4.71e-05	0.000422	CcSEcCtD
Rifabutin—Pain—Paclitaxel—breast cancer	4.7e-05	0.000422	CcSEcCtD
Rifabutin—Confusional state—Docetaxel—breast cancer	4.7e-05	0.000422	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	4.67e-05	0.000419	CcSEcCtD
Rifabutin—Hepatobiliary disease—Epirubicin—breast cancer	4.66e-05	0.000418	CcSEcCtD
Rifabutin—Pruritus—Gemcitabine—breast cancer	4.64e-05	0.000417	CcSEcCtD
Rifabutin—Nausea—Thiotepa—breast cancer	4.64e-05	0.000416	CcSEcCtD
Rifabutin—Diarrhoea—Irinotecan—breast cancer	4.61e-05	0.000414	CcSEcCtD
Rifabutin—Diarrhoea—Mitoxantrone—breast cancer	4.61e-05	0.000414	CcSEcCtD
Rifabutin—Agranulocytosis—Epirubicin—breast cancer	4.6e-05	0.000413	CcSEcCtD
Rifabutin—Shock—Docetaxel—breast cancer	4.58e-05	0.000411	CcSEcCtD
Rifabutin—Pruritus—Fluorouracil—breast cancer	4.57e-05	0.00041	CcSEcCtD
Rifabutin—Thrombocytopenia—Docetaxel—breast cancer	4.56e-05	0.000409	CcSEcCtD
Rifabutin—Confusional state—Capecitabine—breast cancer	4.55e-05	0.000408	CcSEcCtD
Rifabutin—Feeling abnormal—Paclitaxel—breast cancer	4.53e-05	0.000406	CcSEcCtD
Rifabutin—Skin disorder—Docetaxel—breast cancer	4.53e-05	0.000406	CcSEcCtD
Rifabutin—Gastrointestinal pain—Paclitaxel—breast cancer	4.49e-05	0.000403	CcSEcCtD
Rifabutin—Diarrhoea—Gemcitabine—breast cancer	4.49e-05	0.000403	CcSEcCtD
Rifabutin—Jaundice—Doxorubicin—breast cancer	4.44e-05	0.000399	CcSEcCtD
Rifabutin—Anorexia—Docetaxel—breast cancer	4.44e-05	0.000399	CcSEcCtD
Rifabutin—Shock—Capecitabine—breast cancer	4.44e-05	0.000398	CcSEcCtD
Rifabutin—Hepatitis—Epirubicin—breast cancer	4.42e-05	0.000397	CcSEcCtD
Rifabutin—Eye disorder—Methotrexate—breast cancer	4.42e-05	0.000396	CcSEcCtD
Rifabutin—Diarrhoea—Fluorouracil—breast cancer	4.42e-05	0.000396	CcSEcCtD
Rifabutin—Thrombocytopenia—Capecitabine—breast cancer	4.42e-05	0.000396	CcSEcCtD
Rifabutin—Skin disorder—Capecitabine—breast cancer	4.38e-05	0.000393	CcSEcCtD
Rifabutin—Connective tissue disorder—Epirubicin—breast cancer	4.35e-05	0.00039	CcSEcCtD
Rifabutin—Abdominal pain—Paclitaxel—breast cancer	4.34e-05	0.00039	CcSEcCtD
Rifabutin—Body temperature increased—Paclitaxel—breast cancer	4.34e-05	0.00039	CcSEcCtD
Rifabutin—Hepatobiliary disease—Doxorubicin—breast cancer	4.31e-05	0.000387	CcSEcCtD
Rifabutin—Anorexia—Capecitabine—breast cancer	4.3e-05	0.000386	CcSEcCtD
Rifabutin—Vomiting—Irinotecan—breast cancer	4.28e-05	0.000385	CcSEcCtD
Rifabutin—Vomiting—Mitoxantrone—breast cancer	4.28e-05	0.000385	CcSEcCtD
Rifabutin—Immune system disorder—Methotrexate—breast cancer	4.27e-05	0.000383	CcSEcCtD
Rifabutin—Agranulocytosis—Doxorubicin—breast cancer	4.25e-05	0.000382	CcSEcCtD
Rifabutin—Rash—Irinotecan—breast cancer	4.25e-05	0.000381	CcSEcCtD
Rifabutin—Rash—Mitoxantrone—breast cancer	4.25e-05	0.000381	CcSEcCtD
Rifabutin—Dermatitis—Mitoxantrone—breast cancer	4.25e-05	0.000381	CcSEcCtD
Rifabutin—Dermatitis—Irinotecan—breast cancer	4.25e-05	0.000381	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Docetaxel—breast cancer	4.24e-05	0.000381	CcSEcCtD
Rifabutin—Headache—Mitoxantrone—breast cancer	4.22e-05	0.000379	CcSEcCtD
Rifabutin—Headache—Irinotecan—breast cancer	4.22e-05	0.000379	CcSEcCtD
Rifabutin—Insomnia—Docetaxel—breast cancer	4.21e-05	0.000378	CcSEcCtD
Rifabutin—Paraesthesia—Docetaxel—breast cancer	4.18e-05	0.000375	CcSEcCtD
Rifabutin—Vomiting—Gemcitabine—breast cancer	4.17e-05	0.000375	CcSEcCtD
Rifabutin—Dyspnoea—Docetaxel—breast cancer	4.15e-05	0.000373	CcSEcCtD
Rifabutin—Rash—Gemcitabine—breast cancer	4.14e-05	0.000371	CcSEcCtD
Rifabutin—Dermatitis—Gemcitabine—breast cancer	4.14e-05	0.000371	CcSEcCtD
Rifabutin—Eye disorder—Epirubicin—breast cancer	4.13e-05	0.000371	CcSEcCtD
Rifabutin—Headache—Gemcitabine—breast cancer	4.11e-05	0.000369	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Capecitabine—breast cancer	4.11e-05	0.000369	CcSEcCtD
Rifabutin—Vomiting—Fluorouracil—breast cancer	4.1e-05	0.000368	CcSEcCtD
Rifabutin—Dyspepsia—Docetaxel—breast cancer	4.1e-05	0.000368	CcSEcCtD
Rifabutin—Hepatitis—Doxorubicin—breast cancer	4.09e-05	0.000367	CcSEcCtD
Rifabutin—Insomnia—Capecitabine—breast cancer	4.08e-05	0.000366	CcSEcCtD
Rifabutin—Rash—Fluorouracil—breast cancer	4.07e-05	0.000365	CcSEcCtD
Rifabutin—Dermatitis—Fluorouracil—breast cancer	4.07e-05	0.000365	CcSEcCtD
Rifabutin—Paraesthesia—Capecitabine—breast cancer	4.05e-05	0.000363	CcSEcCtD
Rifabutin—Decreased appetite—Docetaxel—breast cancer	4.05e-05	0.000363	CcSEcCtD
Rifabutin—Hypersensitivity—Paclitaxel—breast cancer	4.05e-05	0.000363	CcSEcCtD
Rifabutin—Headache—Fluorouracil—breast cancer	4.04e-05	0.000363	CcSEcCtD
Rifabutin—Dysgeusia—Methotrexate—breast cancer	4.03e-05	0.000362	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Docetaxel—breast cancer	4.02e-05	0.000361	CcSEcCtD
Rifabutin—Connective tissue disorder—Doxorubicin—breast cancer	4.02e-05	0.000361	CcSEcCtD
Rifabutin—Dyspnoea—Capecitabine—breast cancer	4.02e-05	0.000361	CcSEcCtD
Rifabutin—Nausea—Mitoxantrone—breast cancer	4e-05	0.000359	CcSEcCtD
Rifabutin—Nausea—Irinotecan—breast cancer	4e-05	0.000359	CcSEcCtD
Rifabutin—Immune system disorder—Epirubicin—breast cancer	3.99e-05	0.000359	CcSEcCtD
Rifabutin—Pain—Docetaxel—breast cancer	3.98e-05	0.000358	CcSEcCtD
Rifabutin—Dyspepsia—Capecitabine—breast cancer	3.97e-05	0.000356	CcSEcCtD
Rifabutin—Asthenia—Paclitaxel—breast cancer	3.94e-05	0.000354	CcSEcCtD
Rifabutin—Decreased appetite—Capecitabine—breast cancer	3.92e-05	0.000352	CcSEcCtD
Rifabutin—Nausea—Gemcitabine—breast cancer	3.9e-05	0.00035	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Capecitabine—breast cancer	3.89e-05	0.000349	CcSEcCtD
Rifabutin—Pruritus—Paclitaxel—breast cancer	3.89e-05	0.000349	CcSEcCtD
Rifabutin—Pain—Capecitabine—breast cancer	3.86e-05	0.000346	CcSEcCtD
Rifabutin—Feeling abnormal—Docetaxel—breast cancer	3.84e-05	0.000345	CcSEcCtD
Rifabutin—Nausea—Fluorouracil—breast cancer	3.83e-05	0.000344	CcSEcCtD
Rifabutin—Eye disorder—Doxorubicin—breast cancer	3.82e-05	0.000343	CcSEcCtD
Rifabutin—Gastrointestinal pain—Docetaxel—breast cancer	3.81e-05	0.000342	CcSEcCtD
Rifabutin—Anaemia—Methotrexate—breast cancer	3.8e-05	0.000341	CcSEcCtD
Rifabutin—Flatulence—Epirubicin—breast cancer	3.79e-05	0.00034	CcSEcCtD
Rifabutin—Dysgeusia—Epirubicin—breast cancer	3.77e-05	0.000338	CcSEcCtD
Rifabutin—Diarrhoea—Paclitaxel—breast cancer	3.76e-05	0.000337	CcSEcCtD
Rifabutin—Feeling abnormal—Capecitabine—breast cancer	3.72e-05	0.000334	CcSEcCtD
Rifabutin—Immune system disorder—Doxorubicin—breast cancer	3.7e-05	0.000332	CcSEcCtD
Rifabutin—Gastrointestinal pain—Capecitabine—breast cancer	3.69e-05	0.000331	CcSEcCtD
Rifabutin—Body temperature increased—Docetaxel—breast cancer	3.68e-05	0.000331	CcSEcCtD
Rifabutin—Abdominal pain—Docetaxel—breast cancer	3.68e-05	0.000331	CcSEcCtD
Rifabutin—Leukopenia—Methotrexate—breast cancer	3.68e-05	0.00033	CcSEcCtD
Rifabutin—Body temperature increased—Capecitabine—breast cancer	3.57e-05	0.00032	CcSEcCtD
Rifabutin—Abdominal pain—Capecitabine—breast cancer	3.57e-05	0.00032	CcSEcCtD
Rifabutin—Convulsion—Methotrexate—breast cancer	3.56e-05	0.00032	CcSEcCtD
Rifabutin—Anaemia—Epirubicin—breast cancer	3.56e-05	0.000319	CcSEcCtD
Rifabutin—Flatulence—Doxorubicin—breast cancer	3.51e-05	0.000315	CcSEcCtD
Rifabutin—Chest pain—Methotrexate—breast cancer	3.5e-05	0.000314	CcSEcCtD
Rifabutin—Myalgia—Methotrexate—breast cancer	3.5e-05	0.000314	CcSEcCtD
Rifabutin—Arthralgia—Methotrexate—breast cancer	3.5e-05	0.000314	CcSEcCtD
Rifabutin—Vomiting—Paclitaxel—breast cancer	3.49e-05	0.000314	CcSEcCtD
Rifabutin—Dysgeusia—Doxorubicin—breast cancer	3.49e-05	0.000313	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.48e-05	0.000312	CcSEcCtD
Rifabutin—Rash—Paclitaxel—breast cancer	3.47e-05	0.000311	CcSEcCtD
Rifabutin—Dermatitis—Paclitaxel—breast cancer	3.46e-05	0.000311	CcSEcCtD
Rifabutin—Leukopenia—Epirubicin—breast cancer	3.45e-05	0.000309	CcSEcCtD
Rifabutin—Headache—Paclitaxel—breast cancer	3.44e-05	0.000309	CcSEcCtD
Rifabutin—Hypersensitivity—Docetaxel—breast cancer	3.43e-05	0.000308	CcSEcCtD
Rifabutin—Confusional state—Methotrexate—breast cancer	3.39e-05	0.000304	CcSEcCtD
Rifabutin—Asthenia—Docetaxel—breast cancer	3.34e-05	0.0003	CcSEcCtD
Rifabutin—Convulsion—Epirubicin—breast cancer	3.34e-05	0.000299	CcSEcCtD
Rifabutin—Hypersensitivity—Capecitabine—breast cancer	3.32e-05	0.000298	CcSEcCtD
Rifabutin—Pruritus—Docetaxel—breast cancer	3.3e-05	0.000296	CcSEcCtD
Rifabutin—Anaemia—Doxorubicin—breast cancer	3.29e-05	0.000295	CcSEcCtD
Rifabutin—Thrombocytopenia—Methotrexate—breast cancer	3.29e-05	0.000295	CcSEcCtD
Rifabutin—Myalgia—Epirubicin—breast cancer	3.28e-05	0.000294	CcSEcCtD
Rifabutin—Arthralgia—Epirubicin—breast cancer	3.28e-05	0.000294	CcSEcCtD
Rifabutin—Chest pain—Epirubicin—breast cancer	3.28e-05	0.000294	CcSEcCtD
Rifabutin—Nausea—Paclitaxel—breast cancer	3.26e-05	0.000293	CcSEcCtD
Rifabutin—Skin disorder—Methotrexate—breast cancer	3.26e-05	0.000293	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.26e-05	0.000292	CcSEcCtD
Rifabutin—Asthenia—Capecitabine—breast cancer	3.24e-05	0.00029	CcSEcCtD
Rifabutin—Anorexia—Methotrexate—breast cancer	3.2e-05	0.000287	CcSEcCtD
Rifabutin—Pruritus—Capecitabine—breast cancer	3.19e-05	0.000286	CcSEcCtD
Rifabutin—Leukopenia—Doxorubicin—breast cancer	3.19e-05	0.000286	CcSEcCtD
Rifabutin—Diarrhoea—Docetaxel—breast cancer	3.19e-05	0.000286	CcSEcCtD
Rifabutin—Confusional state—Epirubicin—breast cancer	3.17e-05	0.000284	CcSEcCtD
Rifabutin—Shock—Epirubicin—breast cancer	3.09e-05	0.000277	CcSEcCtD
Rifabutin—Convulsion—Doxorubicin—breast cancer	3.09e-05	0.000277	CcSEcCtD
Rifabutin—Diarrhoea—Capecitabine—breast cancer	3.09e-05	0.000277	CcSEcCtD
Rifabutin—Thrombocytopenia—Epirubicin—breast cancer	3.08e-05	0.000276	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Methotrexate—breast cancer	3.06e-05	0.000275	CcSEcCtD
Rifabutin—Skin disorder—Epirubicin—breast cancer	3.05e-05	0.000274	CcSEcCtD
Rifabutin—Insomnia—Methotrexate—breast cancer	3.04e-05	0.000273	CcSEcCtD
Rifabutin—Chest pain—Doxorubicin—breast cancer	3.03e-05	0.000272	CcSEcCtD
Rifabutin—Arthralgia—Doxorubicin—breast cancer	3.03e-05	0.000272	CcSEcCtD
Rifabutin—Myalgia—Doxorubicin—breast cancer	3.03e-05	0.000272	CcSEcCtD
Rifabutin—Paraesthesia—Methotrexate—breast cancer	3.02e-05	0.000271	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.01e-05	0.00027	CcSEcCtD
Rifabutin—Anorexia—Epirubicin—breast cancer	3e-05	0.000269	CcSEcCtD
Rifabutin—Dyspnoea—Methotrexate—breast cancer	2.99e-05	0.000269	CcSEcCtD
Rifabutin—Vomiting—Docetaxel—breast cancer	2.96e-05	0.000266	CcSEcCtD
Rifabutin—Dyspepsia—Methotrexate—breast cancer	2.96e-05	0.000265	CcSEcCtD
Rifabutin—Rash—Docetaxel—breast cancer	2.94e-05	0.000264	CcSEcCtD
Rifabutin—Dermatitis—Docetaxel—breast cancer	2.93e-05	0.000263	CcSEcCtD
Rifabutin—Confusional state—Doxorubicin—breast cancer	2.93e-05	0.000263	CcSEcCtD
Rifabutin—Decreased appetite—Methotrexate—breast cancer	2.92e-05	0.000262	CcSEcCtD
Rifabutin—Headache—Docetaxel—breast cancer	2.92e-05	0.000262	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Methotrexate—breast cancer	2.9e-05	0.00026	CcSEcCtD
Rifabutin—Pain—Methotrexate—breast cancer	2.87e-05	0.000258	CcSEcCtD
Rifabutin—Vomiting—Capecitabine—breast cancer	2.87e-05	0.000257	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Epirubicin—breast cancer	2.86e-05	0.000257	CcSEcCtD
Rifabutin—Shock—Doxorubicin—breast cancer	2.86e-05	0.000257	CcSEcCtD
Rifabutin—Thrombocytopenia—Doxorubicin—breast cancer	2.85e-05	0.000255	CcSEcCtD
Rifabutin—Rash—Capecitabine—breast cancer	2.84e-05	0.000255	CcSEcCtD
Rifabutin—Insomnia—Epirubicin—breast cancer	2.84e-05	0.000255	CcSEcCtD
Rifabutin—Dermatitis—Capecitabine—breast cancer	2.84e-05	0.000255	CcSEcCtD
Rifabutin—Headache—Capecitabine—breast cancer	2.83e-05	0.000254	CcSEcCtD
Rifabutin—Skin disorder—Doxorubicin—breast cancer	2.82e-05	0.000253	CcSEcCtD
Rifabutin—Paraesthesia—Epirubicin—breast cancer	2.82e-05	0.000253	CcSEcCtD
Rifabutin—Dyspnoea—Epirubicin—breast cancer	2.8e-05	0.000251	CcSEcCtD
Rifabutin—Anorexia—Doxorubicin—breast cancer	2.77e-05	0.000249	CcSEcCtD
Rifabutin—Nausea—Docetaxel—breast cancer	2.77e-05	0.000248	CcSEcCtD
Rifabutin—Feeling abnormal—Methotrexate—breast cancer	2.77e-05	0.000248	CcSEcCtD
Rifabutin—Dyspepsia—Epirubicin—breast cancer	2.77e-05	0.000248	CcSEcCtD
Rifabutin—Gastrointestinal pain—Methotrexate—breast cancer	2.75e-05	0.000246	CcSEcCtD
Rifabutin—Decreased appetite—Epirubicin—breast cancer	2.73e-05	0.000245	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Epirubicin—breast cancer	2.71e-05	0.000243	CcSEcCtD
Rifabutin—Pain—Epirubicin—breast cancer	2.69e-05	0.000241	CcSEcCtD
Rifabutin—Nausea—Capecitabine—breast cancer	2.68e-05	0.00024	CcSEcCtD
Rifabutin—Abdominal pain—Methotrexate—breast cancer	2.65e-05	0.000238	CcSEcCtD
Rifabutin—Body temperature increased—Methotrexate—breast cancer	2.65e-05	0.000238	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.65e-05	0.000238	CcSEcCtD
Rifabutin—Insomnia—Doxorubicin—breast cancer	2.63e-05	0.000236	CcSEcCtD
Rifabutin—Paraesthesia—Doxorubicin—breast cancer	2.61e-05	0.000234	CcSEcCtD
Rifabutin—Dyspnoea—Doxorubicin—breast cancer	2.59e-05	0.000233	CcSEcCtD
Rifabutin—Feeling abnormal—Epirubicin—breast cancer	2.59e-05	0.000232	CcSEcCtD
Rifabutin—Gastrointestinal pain—Epirubicin—breast cancer	2.57e-05	0.000231	CcSEcCtD
Rifabutin—Dyspepsia—Doxorubicin—breast cancer	2.56e-05	0.00023	CcSEcCtD
Rifabutin—Decreased appetite—Doxorubicin—breast cancer	2.53e-05	0.000227	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Doxorubicin—breast cancer	2.51e-05	0.000225	CcSEcCtD
Rifabutin—Pain—Doxorubicin—breast cancer	2.49e-05	0.000223	CcSEcCtD
Rifabutin—Body temperature increased—Epirubicin—breast cancer	2.48e-05	0.000223	CcSEcCtD
Rifabutin—Abdominal pain—Epirubicin—breast cancer	2.48e-05	0.000223	CcSEcCtD
Rifabutin—Hypersensitivity—Methotrexate—breast cancer	2.47e-05	0.000222	CcSEcCtD
Rifabutin—Asthenia—Methotrexate—breast cancer	2.41e-05	0.000216	CcSEcCtD
Rifabutin—Feeling abnormal—Doxorubicin—breast cancer	2.4e-05	0.000215	CcSEcCtD
Rifabutin—Gastrointestinal pain—Doxorubicin—breast cancer	2.38e-05	0.000213	CcSEcCtD
Rifabutin—Pruritus—Methotrexate—breast cancer	2.38e-05	0.000213	CcSEcCtD
Rifabutin—Hypersensitivity—Epirubicin—breast cancer	2.32e-05	0.000208	CcSEcCtD
Rifabutin—Body temperature increased—Doxorubicin—breast cancer	2.3e-05	0.000206	CcSEcCtD
Rifabutin—Abdominal pain—Doxorubicin—breast cancer	2.3e-05	0.000206	CcSEcCtD
Rifabutin—Diarrhoea—Methotrexate—breast cancer	2.3e-05	0.000206	CcSEcCtD
Rifabutin—Asthenia—Epirubicin—breast cancer	2.25e-05	0.000202	CcSEcCtD
Rifabutin—Pruritus—Epirubicin—breast cancer	2.22e-05	0.0002	CcSEcCtD
Rifabutin—Diarrhoea—Epirubicin—breast cancer	2.15e-05	0.000193	CcSEcCtD
Rifabutin—Hypersensitivity—Doxorubicin—breast cancer	2.14e-05	0.000192	CcSEcCtD
Rifabutin—Vomiting—Methotrexate—breast cancer	2.13e-05	0.000192	CcSEcCtD
Rifabutin—Rash—Methotrexate—breast cancer	2.12e-05	0.00019	CcSEcCtD
Rifabutin—Dermatitis—Methotrexate—breast cancer	2.12e-05	0.00019	CcSEcCtD
Rifabutin—Headache—Methotrexate—breast cancer	2.1e-05	0.000189	CcSEcCtD
Rifabutin—Asthenia—Doxorubicin—breast cancer	2.09e-05	0.000187	CcSEcCtD
Rifabutin—Pruritus—Doxorubicin—breast cancer	2.06e-05	0.000185	CcSEcCtD
Rifabutin—Vomiting—Epirubicin—breast cancer	2e-05	0.000179	CcSEcCtD
Rifabutin—Nausea—Methotrexate—breast cancer	1.99e-05	0.000179	CcSEcCtD
Rifabutin—Diarrhoea—Doxorubicin—breast cancer	1.99e-05	0.000179	CcSEcCtD
Rifabutin—Rash—Epirubicin—breast cancer	1.98e-05	0.000178	CcSEcCtD
Rifabutin—Dermatitis—Epirubicin—breast cancer	1.98e-05	0.000178	CcSEcCtD
Rifabutin—Headache—Epirubicin—breast cancer	1.97e-05	0.000177	CcSEcCtD
Rifabutin—Nausea—Epirubicin—breast cancer	1.87e-05	0.000168	CcSEcCtD
Rifabutin—Vomiting—Doxorubicin—breast cancer	1.85e-05	0.000166	CcSEcCtD
Rifabutin—Rash—Doxorubicin—breast cancer	1.83e-05	0.000165	CcSEcCtD
Rifabutin—Dermatitis—Doxorubicin—breast cancer	1.83e-05	0.000164	CcSEcCtD
Rifabutin—Headache—Doxorubicin—breast cancer	1.82e-05	0.000163	CcSEcCtD
Rifabutin—Nausea—Doxorubicin—breast cancer	1.73e-05	0.000155	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—PTEN—breast cancer	4.83e-06	4.55e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOTCH1—breast cancer	4.82e-06	4.55e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CHST9—breast cancer	4.81e-06	4.53e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AKT1—breast cancer	4.78e-06	4.51e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK8—breast cancer	4.73e-06	4.46e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ANGPTL4—breast cancer	4.72e-06	4.45e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ESRRA—breast cancer	4.72e-06	4.45e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APC—breast cancer	4.72e-06	4.45e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CG—breast cancer	4.72e-06	4.45e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KIT—breast cancer	4.72e-06	4.45e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NOS3—breast cancer	4.68e-06	4.42e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGF—breast cancer	4.66e-06	4.4e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CTNNB1—breast cancer	4.58e-06	4.31e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—COX11—breast cancer	4.56e-06	4.3e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	4.49e-06	4.23e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—SRC—breast cancer	4.48e-06	4.22e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPI—breast cancer	4.48e-06	4.22e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HADHB—breast cancer	4.48e-06	4.22e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN1A—breast cancer	4.47e-06	4.21e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTEN—breast cancer	4.46e-06	4.21e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—BRAF—breast cancer	4.43e-06	4.18e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CB—breast cancer	4.32e-06	4.08e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—STAT3—breast cancer	4.32e-06	4.07e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IGF1—breast cancer	4.32e-06	4.07e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT2—breast cancer	4.32e-06	4.07e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—breast cancer	4.28e-06	4.04e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	4.28e-06	4.04e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALDH7A1—breast cancer	4.27e-06	4.03e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALDH1A1—breast cancer	4.27e-06	4.03e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	4.22e-06	3.98e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SHMT1—breast cancer	4.17e-06	3.93e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CDA—breast cancer	4.17e-06	3.93e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CD—breast cancer	4.15e-06	3.91e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SRC—breast cancer	4.14e-06	3.9e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK3—breast cancer	4.13e-06	3.89e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SERPINE1—breast cancer	4.1e-06	3.87e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NME1—breast cancer	4.09e-06	3.86e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ADSL—breast cancer	4.09e-06	3.86e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—FHL2—breast cancer	4.09e-06	3.86e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—UMPS—breast cancer	4.09e-06	3.86e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PHGDH—breast cancer	4.09e-06	3.86e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LDHB—breast cancer	4.01e-06	3.78e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HPSE—breast cancer	4.01e-06	3.78e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—BRIP1—breast cancer	4.01e-06	3.78e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC2A5—breast cancer	4.01e-06	3.78e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLCO1B1—breast cancer	4.01e-06	3.78e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—STAT3—breast cancer	3.99e-06	3.76e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—breast cancer	3.93e-06	3.7e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOS3—breast cancer	3.92e-06	3.69e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APRT—breast cancer	3.88e-06	3.65e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK3—breast cancer	3.81e-06	3.59e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTA3—breast cancer	3.81e-06	3.59e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HMMR—breast cancer	3.81e-06	3.59e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCC1—breast cancer	3.81e-06	3.59e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTEN—breast cancer	3.74e-06	3.52e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MDM2—breast cancer	3.72e-06	3.5e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KRAS—breast cancer	3.71e-06	3.5e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—breast cancer	3.71e-06	3.49e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RAF1—breast cancer	3.7e-06	3.49e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TGFB1—breast cancer	3.7e-06	3.49e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RELA—breast cancer	3.69e-06	3.47e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARGC1B—breast cancer	3.69e-06	3.47e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB2—breast cancer	3.66e-06	3.45e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ESRRA—breast cancer	3.64e-06	3.43e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ANGPTL4—breast cancer	3.64e-06	3.43e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—breast cancer	3.63e-06	3.42e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MTOR—breast cancer	3.61e-06	3.41e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CB—breast cancer	3.61e-06	3.41e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	3.59e-06	3.38e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	3.59e-06	3.38e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CA9—breast cancer	3.48e-06	3.28e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTA4—breast cancer	3.48e-06	3.28e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL8—breast cancer	3.47e-06	3.27e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPI—breast cancer	3.45e-06	3.26e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HADHB—breast cancer	3.45e-06	3.26e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	3.44e-06	3.24e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KRAS—breast cancer	3.43e-06	3.23e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CA—breast cancer	3.41e-06	3.21e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	3.4e-06	3.21e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1B—breast cancer	3.39e-06	3.2e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTA2—breast cancer	3.39e-06	3.2e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPX2—breast cancer	3.39e-06	3.2e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SULT1A1—breast cancer	3.35e-06	3.16e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPX4—breast cancer	3.35e-06	3.16e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CASP3—breast cancer	3.32e-06	3.13e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL2—breast cancer	3.32e-06	3.13e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALDH1A1—breast cancer	3.3e-06	3.11e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALDH7A1—breast cancer	3.3e-06	3.11e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTA1—breast cancer	3.27e-06	3.08e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—IDH1—breast cancer	3.27e-06	3.08e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCND1—breast cancer	3.24e-06	3.05e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NAT2—breast cancer	3.24e-06	3.05e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JUN—breast cancer	3.23e-06	3.04e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CTNNB1—breast cancer	3.2e-06	3.02e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—FHL2—breast cancer	3.16e-06	2.98e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NME1—breast cancer	3.16e-06	2.98e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ADSL—breast cancer	3.16e-06	2.98e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—UMPS—breast cancer	3.16e-06	2.98e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PHGDH—breast cancer	3.16e-06	2.98e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HRAS—breast cancer	3.15e-06	2.97e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CA—breast cancer	3.15e-06	2.97e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—breast cancer	3.14e-06	2.96e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1A—breast cancer	3.13e-06	2.95e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTEN—breast cancer	3.12e-06	2.94e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—BRIP1—breast cancer	3.1e-06	2.92e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HPSE—breast cancer	3.1e-06	2.92e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LDHB—breast cancer	3.1e-06	2.92e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK8—breast cancer	3.06e-06	2.88e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6—breast cancer	3.02e-06	2.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTA3—breast cancer	2.94e-06	2.77e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCC1—breast cancer	2.94e-06	2.77e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HMMR—breast cancer	2.94e-06	2.77e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.93e-06	2.76e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HRAS—breast cancer	2.91e-06	2.74e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SRC—breast cancer	2.9e-06	2.73e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARGC1B—breast cancer	2.84e-06	2.68e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MED12—breast cancer	2.84e-06	2.67e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—DPYD—breast cancer	2.84e-06	2.67e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—breast cancer	2.82e-06	2.66e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STAT3—breast cancer	2.79e-06	2.63e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALDOA—breast cancer	2.79e-06	2.63e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6—breast cancer	2.79e-06	2.63e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AKT1—breast cancer	2.78e-06	2.62e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NCOA3—breast cancer	2.71e-06	2.56e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC2A2—breast cancer	2.69e-06	2.54e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTA4—breast cancer	2.69e-06	2.53e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CA9—breast cancer	2.69e-06	2.53e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK3—breast cancer	2.67e-06	2.52e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.66e-06	2.51e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCG2—breast cancer	2.64e-06	2.49e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CPT1A—breast cancer	2.64e-06	2.49e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTR—breast cancer	2.64e-06	2.49e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CA—breast cancer	2.64e-06	2.48e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPX2—breast cancer	2.62e-06	2.47e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTA2—breast cancer	2.62e-06	2.47e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—breast cancer	2.6e-06	2.45e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TGFB1—breast cancer	2.59e-06	2.44e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HPGDS—breast cancer	2.59e-06	2.44e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPX4—breast cancer	2.59e-06	2.44e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SULT1A1—breast cancer	2.59e-06	2.44e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT1—breast cancer	2.57e-06	2.42e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HBA1—breast cancer	2.57e-06	2.42e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—breast cancer	2.54e-06	2.39e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—IDH1—breast cancer	2.53e-06	2.38e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTA1—breast cancer	2.53e-06	2.38e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTT1—breast cancer	2.51e-06	2.37e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ACHE—breast cancer	2.51e-06	2.37e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NAT2—breast cancer	2.5e-06	2.35e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KRAS—breast cancer	2.4e-06	2.26e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP17A1—breast cancer	2.37e-06	2.24e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ENO1—breast cancer	2.35e-06	2.22e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS1—breast cancer	2.35e-06	2.22e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.34e-06	2.21e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.31e-06	2.18e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP2D6—breast cancer	2.31e-06	2.17e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NCOA2—breast cancer	2.26e-06	2.13e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CA—breast cancer	2.2e-06	2.08e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—FASN—breast cancer	2.19e-06	2.07e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—DPYD—breast cancer	2.19e-06	2.06e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MED12—breast cancer	2.19e-06	2.06e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—BCHE—breast cancer	2.19e-06	2.06e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC5A5—breast cancer	2.16e-06	2.04e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALDOA—breast cancer	2.16e-06	2.03e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKT1—breast cancer	2.15e-06	2.03e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—breast cancer	2.13e-06	2.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NCOA3—breast cancer	2.09e-06	1.97e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NQO1—breast cancer	2.09e-06	1.97e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC2A1—breast cancer	2.09e-06	1.97e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC2A2—breast cancer	2.08e-06	1.96e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.04e-06	1.92e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HRAS—breast cancer	2.04e-06	1.92e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTR—breast cancer	2.04e-06	1.92e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCG2—breast cancer	2.04e-06	1.92e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CPT1A—breast cancer	2.04e-06	1.92e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP3A4—breast cancer	2.03e-06	1.92e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.02e-06	1.91e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP1B1—breast cancer	2e-06	1.88e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HPGDS—breast cancer	2e-06	1.88e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HBA1—breast cancer	1.98e-06	1.87e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.96e-06	1.85e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6—breast cancer	1.95e-06	1.84e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTT1—breast cancer	1.94e-06	1.83e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ACHE—breast cancer	1.94e-06	1.83e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NCOA1—breast cancer	1.91e-06	1.8e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—STK11—breast cancer	1.88e-06	1.77e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP19A1—breast cancer	1.88e-06	1.77e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP17A1—breast cancer	1.83e-06	1.73e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ENO1—breast cancer	1.81e-06	1.71e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS1—breast cancer	1.81e-06	1.71e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT1—breast cancer	1.8e-06	1.7e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP2D6—breast cancer	1.78e-06	1.68e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.76e-06	1.66e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—COMT—breast cancer	1.75e-06	1.65e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NCOA2—breast cancer	1.75e-06	1.65e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTP1—breast cancer	1.74e-06	1.64e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HMOX1—breast cancer	1.72e-06	1.62e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ITPR1—breast cancer	1.71e-06	1.61e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—FASN—breast cancer	1.69e-06	1.6e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—BCHE—breast cancer	1.69e-06	1.59e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC5A5—breast cancer	1.67e-06	1.57e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCB1—breast cancer	1.65e-06	1.55e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TYMS—breast cancer	1.62e-06	1.52e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NQO1—breast cancer	1.61e-06	1.52e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC2A1—breast cancer	1.61e-06	1.52e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTM1—breast cancer	1.6e-06	1.51e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NCOR1—breast cancer	1.6e-06	1.51e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.6e-06	1.51e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP1B1—breast cancer	1.54e-06	1.45e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPX1—breast cancer	1.53e-06	1.44e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP1A1—breast cancer	1.51e-06	1.43e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.51e-06	1.43e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ERCC2—breast cancer	1.5e-06	1.42e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NCOA1—breast cancer	1.47e-06	1.39e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—STK11—breast cancer	1.45e-06	1.37e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP19A1—breast cancer	1.45e-06	1.37e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTHFR—breast cancer	1.41e-06	1.33e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—COMT—breast cancer	1.35e-06	1.27e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTP1—breast cancer	1.34e-06	1.27e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HMOX1—breast cancer	1.32e-06	1.25e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ITPR1—breast cancer	1.32e-06	1.25e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CAV1—breast cancer	1.3e-06	1.23e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCB1—breast cancer	1.27e-06	1.2e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TYMS—breast cancer	1.25e-06	1.18e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.24e-06	1.17e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.23e-06	1.16e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTM1—breast cancer	1.23e-06	1.16e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NCOR1—breast cancer	1.23e-06	1.16e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CG—breast cancer	1.19e-06	1.12e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPX1—breast cancer	1.18e-06	1.11e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP1A1—breast cancer	1.17e-06	1.1e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ERCC2—breast cancer	1.16e-06	1.09e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTHFR—breast cancer	1.09e-06	1.03e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CD—breast cancer	1.04e-06	9.83e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALB—breast cancer	1.03e-06	9.71e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CAV1—breast cancer	1.01e-06	9.48e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NOS3—breast cancer	9.85e-07	9.29e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CG—breast cancer	9.16e-07	8.63e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CB—breast cancer	9.09e-07	8.57e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—breast cancer	9.01e-07	8.49e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CD—breast cancer	8.05e-07	7.59e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALB—breast cancer	7.95e-07	7.49e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTEN—breast cancer	7.86e-07	7.41e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NOS3—breast cancer	7.6e-07	7.17e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CB—breast cancer	7.02e-07	6.62e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—breast cancer	6.95e-07	6.55e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTEN—breast cancer	6.06e-07	5.72e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CA—breast cancer	5.54e-07	5.23e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKT1—breast cancer	4.53e-07	4.27e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CA—breast cancer	4.28e-07	4.03e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKT1—breast cancer	3.49e-07	3.29e-06	CbGpPWpGaD
